<Anchor>
Corona 19 vaccine may be able to answer the question of when you can see your friends without worry. It has been confirmed that the vaccine of AstraZeneca in the UK is already being produced by our company in Korea while the development of a domestic vaccine is accelerating. .
Reporter Kim Hyung-rae on the report.
<Reporter> There are
currently 3 vaccine candidates being developed in Korea.
Two types of DNA vaccines containing specific genes that make antibodies and a synthetic antigen vaccine that recombined some proteins of the virus.
Among them, one DNA vaccine was approved for clinical trials in June, and the synthetic antigen vaccine was approved for clinical trials on the 23rd.
The remaining DNA vaccine is also awaiting approval of the clinical trial plan by the Ministry of Food and Drug Safety.
[Kwon Jun-wook/President of the National Institute of Health: It is judged that all three kinds of domestic vaccine candidates may be able to initiate clinical trials as soon as possible within this year.] If the
clinical trial is successful, the synthetic antigen vaccine will be in the second half of next year and the DNA vaccine will be in the next year. It is expected that vaccination will be possible.
Among overseas vaccines, SK Bioscience, a Korean company, has begun to consign AstraZeneca vaccine to the UK.
The industry predicted that "Vaccines produced in Korea are not only for clinical use, but also for sale."
The government is negotiating with the headquarters to purchase the AstraZeneca vaccine, which announced the interim results of the phase 3 clinical trial, for 10 million people.
In addition to the vaccine, the health authorities explained that they are also developing a domestic COVID-19 treatment, and they are currently registering patients at 10 medical institutions and conducting clinical trials.